Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 290 participants.

Also called NCT05516446

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 290 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05516446
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Tunisia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05516446. Randomized; single masking; primary purpose treatment. Start 2021-08-25 (actual); primary completion 2022-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent
Acronym
DEBATE
Condition
De Novo Stenosis
Intervention (Device)
DEB for de Novo Lesions
Intervention (Device)
DES for de Novo Lesions
Lead sponsor
General Administration of Military Health, Tunisia (class: research network)
Collaborator
B. Braun Medical International Trading Company Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05516446
Content hash
ca8ada337ee8859251210716cca07416558a95feb253df1696f65d4ef46aa59d